EDOXABAN(Savaysa)NosebleedCoughingup bloodIschemicstrokeELIQUIS(Apixaban)Pradaxa(Dibigatran) AtrialfibrillationBETRIXABAN(Bevyxxa)InternalbleedingDeep veinthrombosisGenericversionnotavailableRapidoff-setStrokeNorequiredbloodmonitoringMoreexpensivethanWarfarinTheeffectivenessis notchanged bydietJointreplacementsurgeryFewernegativeinteractionwith otherdrugsRIVAROXABAN(Xarelto)Twice dailydoses mayincreasechance for noncompliance.Bloodin urineUncontrolledbleedingRapidon-setPulmonaryembolismNot allDOACs haveFDAapprovedantidotesEDOXABAN(Savaysa)NosebleedCoughingup bloodIschemicstrokeELIQUIS(Apixaban)Pradaxa(Dibigatran) AtrialfibrillationBETRIXABAN(Bevyxxa)InternalbleedingDeep veinthrombosisGenericversionnotavailableRapidoff-setStrokeNorequiredbloodmonitoringMoreexpensivethanWarfarinTheeffectivenessis notchanged bydietJointreplacementsurgeryFewernegativeinteractionwith otherdrugsRIVAROXABAN(Xarelto)Twice dailydoses mayincreasechance for noncompliance.Bloodin urineUncontrolledbleedingRapidon-setPulmonaryembolismNot allDOACs haveFDAapprovedantidotes

DIRECT-ACT ORAL ANTICOAGULANTS - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
  1. EDOXABAN(Savaysa)
  2. Nose bleed
  3. Coughing up blood
  4. Ischemic stroke
  5. ELIQUIS (Apixaban)
  6. Pradaxa (Dibigatran)
  7. Atrial fibrillation
  8. BETRIXABAN (Bevyxxa)
  9. Internal bleeding
  10. Deep vein thrombosis
  11. Generic version not available
  12. Rapid off-set
  13. Stroke
  14. No required blood monitoring
  15. More expensive than Warfarin
  16. The effectiveness is not changed by diet
  17. Joint replacement surgery
  18. Fewer negative interaction with other drugs
  19. RIVAROXABAN(Xarelto)
  20. Twice daily doses may increase chance for non compliance.
  21. Blood in urine
  22. Uncontrolled bleeding
  23. Rapid on-set
  24. Pulmonary embolism
  25. Not all DOACs have FDA approved antidotes